ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,502 | -15.6% | 331,668 | -10.5% | 0.30% | -8.1% |
| Q2 2023 | $589,386 | +175.2% | 370,683 | +24.2% | 0.32% | +208.7% |
| Q1 2023 | $214,187 | +23.8% | 298,560 | 0.0% | 0.10% | +2.0% |
| Q4 2022 | $173,016 | -39.1% | 298,560 | 0.0% | 0.10% | -41.4% |
| Q3 2022 | $284,000 | -33.2% | 298,560 | +20.0% | 0.17% | -30.4% |
| Q2 2022 | $425,000 | – | 248,800 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |